D
Protagonist Therapeutics, Inc. PTGX
$58.36 $2.173.86% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -198.34% -108.85% 496.49% -8.47% -114.77%
Total Depreciation and Amortization 7.92% 50.75% -17.16% -27.47% 8.78%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -21.88% 81.87% -13.57% 0.62% -5.88%
Change in Net Operating Assets -103.11% 174.34% -6,284.51% -100.90% 219.62%
Cash from Operations -122.96% 529.65% -4.72% -110.37% 1,079.34%
Capital Expenditure -49.17% -75.81% 60.00% -2,667.86% 88.43%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 159.26% -1,015.35% 95.95% -136.05% -1,495.39%
Cash from Investing 158.06% -981.97% 95.82% -136.85% -1,551.47%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -75.47% 195.76% -66.55% 368.55% -67.02%
Repurchase of Common Stock 100.00% -- -- -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -74.44% 183.87% -66.55% 368.55% -64.27%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -31.72% 225.19% 84.91% -222.64% 1,392.99%